0001567619-22-004383.txt : 20220214 0001567619-22-004383.hdr.sgml : 20220214 20220214162345 ACCESSION NUMBER: 0001567619-22-004383 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220214 DATE AS OF CHANGE: 20220214 EFFECTIVENESS DATE: 20220214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Athyrium Capital Management, LP CENTRAL INDEX KEY: 0001728001 IRS NUMBER: 263965190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-18509 FILM NUMBER: 22632611 BUSINESS ADDRESS: STREET 1: 505 FIFTH AVENUE, FLOOR 18 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-402-6925 MAIL ADDRESS: STREET 1: 505 FIFTH AVENUE, FLOOR 18 CITY: NEW YORK STATE: NY ZIP: 10017 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001728001 XXXXXXXX 12-31-2021 12-31-2021 Athyrium Capital Management, LP

505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017

13F HOLDINGS REPORT 028-18509 N Andrew Hyman 212-402-6925 /s/ Andrew Hyman New York NY 02-14-2022 0 6 280491 false INFORMATION TABLE 2 form13fInfoTable.xml Progenity Inc. COM 74319F107 62399 29855847 SH SOLE NA 29855847 0 0 Progenity Inc. Note 7.250% 12/0 74319FAB3 75405 103500000 PRN SOLE NA 0 0 103500000 Amryt Pharma PLC Sponsored ADS 03217L106 95658 8857268 SH SOLE NA 8857268 0 0 Recro Pharma Inc. COM 75629F109 3766 2202420 SH SOLE NA 2202420 0 0 CAREMAX INC COM CL A 14171W103 34462 4487220 SH SOLE NA 4487220 0 0 OSMOTICA PHARMACEUTICALS PLC SHS G6S41R101 8801 8148832 SH SOLE NA 8148832 0 0